ReviewHealth promotion perspectives2023
Access to medicines through global health diplomacy.
Review in Health promotion perspectives, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Willingness to pay for National Health Insurance Services and Associated Factors in Africa and Asia: a systematic review and meta-analysis.Frontiers in public health · 2024Pooled it
- Governing AI for Pharmacovigilance in Low-Income Countries: Systems Perspective.Journal of medical Internet research · 2026Article
- Measured and perceived affordability of asthma medications and their associations with medication adherence among adult patients in Ethiopia: A cross-sectional study.Exploratory research in clinical and social pharmacy · 2026Article
- The Role of Research, Quality Improvement, and Training in Achieving Medicines Security in Nigeria: A Cross-Sectional Exploration of Stakeholders' Perspectives.Health science reports · 2026Article
- Exploring global access to healthcare and utilisation for neurocutaneous syndromes: a scoping review protocol.BMJ open · 2026Article
- Advancing Health Equity through 'One World for Health': Insights from the Seventy-Eighth World Health Assembly.Health promotion perspectives · 2026Article
- Socioeconomic Determinants of Access to Medicines Among Romanian Patients with Chronic Diseases: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
- Environmentally Safe and Just Pharmacy: A Framework and Action Plan for Operating within the Earth System Boundary for Novel Entities.Environmental science & technology · 2026Article
- Burden and Impact of Drug Shortages in a Saudi Tertiary Hospital: A Single-Center Cross-Sectional Survey.Healthcare (Basel, Switzerland) · 2026Article
- Article
- Public health diplomacy in Central Asia: a scoping review.Frontiers in public health · 2026Article
- Bridging international borders through global health diplomacy: A comprehensive bibliometric analysis of the state of play and leads for advancing this domain.Health promotion perspectives · 2025Review
- Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council.Diabetologia · 2025Review
- Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025Review
- Access to essential medicines in aspirational districts of India; A multi-site cross sectional study.Journal of family medicine and primary care · 2025Article
- Regional health diplomacy as a health promotion strategy for robust health systems.Health promotion perspectives · 2025Article
- Global Diseases Deserve Global Solutions: Alzheimer's Disease.Neurology international · 2025Review
- The early market access vehicle - An innovative demand-driven model to catalyse introduction of new optimal health products in low- and middle-income countries.Health policy OPEN · 2025Article
- Time and cost involved in measuring access to medicines: the case of Albania.BMC research notes · 2025Article
- The Political Economy of the World Health Organization Model Lists of Essential Medicines.The Milbank quarterly · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The World Health Organisation (WHO) emphasizes that equitable access to safe and affordable medicines is vital to attaining the highest possible standard of health by all. Ensuring equitable access to medicines (ATM) is also a key narrative of the Sustainable Development Goals (SDGs), as SDG 3.8 specifies "access to safe, effective, quality and affordable essential medicines and vaccines for all" as a central component of universal health coverage (UHC). The SDG 3.b emphasizes the need to develop medicines to address persistent treatment gaps. However, around 2 billion people globally have no access to essential medicines, particularly in lower- and middle-income countries. The states' recognition of health as a human right obligates them to ensure access to timely, acceptable, affordable health care. While ATM is inherent in minimizing the treatment gaps, global health diplomacy (GHD) contributes to addressing these gaps and fulfilling the state's embracement of health as a human right.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.